Centerpoint Advisors’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-90
| Closed | -$21K | – | 433 |
|
|
2023
Q4 | $21K | Hold |
90
| – | – | 0.01% | 225 |
|
|
2023
Q3 | $18K | Hold |
90
| – | – | 0.01% | 241 |
|
|
2023
Q2 | $19K | Hold |
90
| – | – | 0.01% | 259 |
|
|
2023
Q1 | $18K | Hold |
90
| – | – | 0.01% | 266 |
|
|
2022
Q4 | $20K | Hold |
90
| – | – | 0.01% | 203 |
|
|
2022
Q3 | $18K | Hold |
90
| – | – | 0.01% | 187 |
|
|
2022
Q2 | $19K | Hold |
90
| – | – | 0.01% | 193 |
|
|
2022
Q1 | $26K | Hold |
90
| – | – | 0.01% | 180 |
|
|
2021
Q4 | $34K | Hold |
90
| – | – | 0.01% | 150 |
|
|
2021
Q3 | $37K | Buy |
90
+10
| +13% | +$4.11K | 0.02% | 138 |
|
|
2021
Q2 | $30K | Buy |
80
+30
| +60% | +$11.3K | 0.01% | 151 |
|
|
2021
Q1 | $14K | Hold |
50
| – | – | 0.01% | 151 |
|
|
2020
Q4 | $12K | Buy |
50
+25
| +100% | +$6K | 0.01% | 154 |
|
|
2020
Q3 | $6K | Buy |
+25
| New | +$6K | ﹤0.01% | 167 |
|